ANIX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Anixa Biosciences Inc (ANIX).


$112.63M Market Cap.

As of 01/12/2025 5:00 PM ET (MRY) • Disclaimer

ANIX Market Cap. (MRY)


ANIX Shares Outstanding (MRY)


ANIX Assets (MRY)


Total Assets

$21.59M

Total Liabilities

$2.70M

Total Investments

$18.65M

ANIX Income (MRY)


Revenue

$0

Net Income

-$12.55M

Operating Expense

$13.83M

ANIX Cash Flow (MRY)


CF Operations

-$7.33M

CF Investing

$4.28M

CF Financing

$3.42M

ANIX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ANIX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$21,591,000 (-15.40%)

$25,522,000 (-16.08%)

$30,412,000 (-16.12%)

$36,257,000 (283.55%)

Assets Current

$21,362,000 (-15.75%)

$25,356,000 (-16.04%)

$30,200,000 (-16.12%)

$36,003,000 (284.29%)

Assets Non-Current

$229,000 (37.95%)

$166,000 (-21.70%)

$212,000 (-16.54%)

$254,000 (201.16%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$19,998,000 (-17.83%)

$24,337,000 (-16.22%)

$29,047,000 (-18.03%)

$35,438,000 (304.48%)

Property Plant & Equipment Net

$229,000 (37.95%)

$166,000 (-21.70%)

$212,000 (-16.54%)

$254,000 (367.43%)

Cash & Equivalents

$1,271,000 (38.91%)

$915,000 (-92.60%)

$12,360,000 (-57.57%)

$29,128,000 (353.91%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$18,653,000 (-18.65%)

$22,929,000 (32.33%)

$17,327,000 (162.57%)

$6,599,000 (149.96%)

Investments Current

$18,653,000 (-18.65%)

$22,929,000 (32.33%)

$17,327,000 (162.57%)

$6,599,000 (149.96%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$173,000 (-35.93%)

$270,000 (474.47%)

$47,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$525,000 (154.85%)

$206,000 (-22.26%)

$265,000 (94.85%)

$136,000 (-41.47%)

Accumulated Retained Earnings (Deficit)

-$240,750,000 (-5.50%)

-$228,196,000 (-4.49%)

-$218,385,000 (-6.64%)

-$204,790,000 (-6.75%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$232,000 (32.57%)

$175,000 (-20.81%)

$221,000 (-14.67%)

$259,000 (369.22%)

Debt Current

$29,000 (-44.23%)

$52,000 (13.04%)

$46,000 (17.95%)

$39,000 (-29.35%)

Debt Non-Current

$203,000 (65.04%)

$123,000 (-29.71%)

$175,000 (-20.45%)

$220,000 (0%)

Total Liabilities

$2,703,000 (25.66%)

$2,151,000 (-2.76%)

$2,212,000 (48.46%)

$1,490,000 (25.36%)

Liabilities Current

$2,500,000 (23.27%)

$2,028,000 (-0.44%)

$2,037,000 (60.39%)

$1,270,000 (6.85%)

Liabilities Non-Current

$203,000 (65.04%)

$123,000 (-29.71%)

$175,000 (-20.45%)

$220,000 (0%)

ANIX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$210,000 (0%)

$0 (0%)

$512,000 (0%)

Cost of Revenue

$0 (0%)

$161,000 (0%)

$0 (0%)

$385,000 (0%)

Selling General & Administrative Expense

$7,435,000 (18.18%)

$6,291,000 (-12.28%)

$7,172,000 (1.40%)

$7,073,000 (26.37%)

Research & Development Expense

$6,396,000 (34.12%)

$4,769,000 (-28.85%)

$6,703,000 (8.29%)

$6,190,000 (41.29%)

Operating Expenses

$13,831,000 (25.05%)

$11,060,000 (-20.29%)

$13,875,000 (4.61%)

$13,263,000 (32.92%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$12,698,000 (-27.88%)

-$9,930,000 (27.89%)

-$13,771,000 (-4.90%)

-$13,128,000 (-30.08%)

Net Income to Non-Controlling Interests

-$144,000 (-21.01%)

-$119,000 (32.39%)

-$176,000 (-1.15%)

-$174,000 (-135.11%)

Net Income

-$12,554,000 (-27.96%)

-$9,811,000 (27.83%)

-$13,595,000 (-4.95%)

-$12,954,000 (-29.30%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$12,554,000 (-27.96%)

-$9,811,000 (27.83%)

-$13,595,000 (-4.95%)

-$12,954,000 (-29.30%)

Weighted Average Shares

$31,898,000 (2.96%)

$30,980,000 (2.00%)

$30,374,000 (6.28%)

$28,579,000 (28.57%)

Weighted Average Shares Diluted

$31,898,000 (2.96%)

$30,980,000 (2.00%)

$30,374,000 (6.28%)

$28,579,000 (28.57%)

Earning Before Interest & Taxes (EBIT)

-$12,554,000 (-27.96%)

-$9,811,000 (27.83%)

-$13,595,000 (-4.95%)

-$12,954,000 (-29.30%)

Gross Profit

$0 (0%)

$49,000 (0%)

$0 (0%)

$127,000 (0%)

Operating Income

-$13,831,000 (-25.61%)

-$11,011,000 (20.64%)

-$13,875,000 (-5.63%)

-$13,136,000 (-31.65%)

ANIX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$4,276,000 (176.33%)

-$5,602,000 (47.78%)

-$10,728,000 (-173.88%)

-$3,917,000 (-1180.94%)

Net Cash Flow from Financing

$3,415,000 (833.06%)

$366,000 (-19.03%)

$452,000 (-98.57%)

$31,566,000 (235.56%)

Net Cash Flow from Operations

-$7,335,000 (-18.13%)

-$6,209,000 (4.36%)

-$6,492,000 (-31.47%)

-$4,938,000 (20.04%)

Net Cash Flow / Change in Cash & Cash Equivalents

$356,000 (103.11%)

-$11,445,000 (31.74%)

-$16,768,000 (-173.83%)

$22,711,000 (676.33%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$7,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$4,276,000 (176.33%)

-$5,602,000 (47.78%)

-$10,728,000 (-170.98%)

-$3,959,000 (-1265.17%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$35,000 (321.65%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$3,415,000 (833.06%)

$366,000 (-19.03%)

$452,000 (-98.57%)

$31,566,000 (235.56%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$4,800,000 (6.34%)

$4,514,000 (-25.96%)

$6,097,000 (-18.74%)

$7,503,000 (91.27%)

Depreciation Amortization & Accretion

$37,000 (-19.57%)

$46,000 (9.52%)

$42,000 (-30.00%)

$60,000 (-33.45%)

ANIX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

23.30%

-

24.80%

Profit Margin

-

-4671.90%

-

-2530.10%

EBITDA Margin

-

-4650.00%

-

-2518.40%

Return on Average Equity (ROAE)

-55.80% (-48.40%)

-37.60% (12.35%)

-42.90% (-1.90%)

-42.10% (70.48%)

Return on Average Assets (ROAA)

-53.30% (-46.83%)

-36.30% (12.53%)

-41.50% (-1.22%)

-41.00% (68.39%)

Return on Sales (ROS)

-

-4671.90%

-

-2530.10%

Return on Invested Capital (ROIC)

-60.70% (-27.79%)

-47.50% (72.62%)

-173.50% (15.37%)

-205.00% (56.29%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-8.97 (9.12%)

-9.88 (20.64%)

-12.44 (-17.40%)

-10.6 (-131.54%)

Price to Sales Ratio (P/S)

-

466.18

-

266.25

Price to Book Ratio (P/B)

5.63 (39.61%)

4.03 (-31.75%)

5.91 (46.64%)

4.03 (-27.93%)

Debt to Equity Ratio (D/E)

0.14 (53.41%)

0.09 (15.79%)

0.08 (80.95%)

0.04 (-69.12%)

Earnings Per Share (EPS)

-0.39 (-21.88%)

-0.32 (28.89%)

-0.45 (0.00%)

-0.45 (0.00%)

Sales Per Share (SPS)

0 (0%)

0.01 (0%)

0 (0%)

0.02 (0%)

Free Cash Flow Per Share (FCFPS)

-0.23 (-15.00%)

-0.2 (6.54%)

-0.21 (-24.42%)

-0.17 (38.35%)

Book Value Per Share (BVPS)

0.63 (-20.23%)

0.79 (-17.78%)

0.96 (-22.90%)

1.24 (214.72%)

Tangible Assets Book Value Per Share (TABVPS)

0.68 (-17.84%)

0.82 (-17.68%)

1 (-21.12%)

1.27 (198.59%)

Enterprise Value Over EBIT (EV/EBIT)

-9 (10.00%)

-10 (9.09%)

-11 (-22.22%)

-9 (-125.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-8.92 (8.49%)

-9.75 (10.56%)

-10.9 (-21.50%)

-8.97 (-106.37%)

Asset Turnover

0 (0%)

0.01 (0%)

0 (0%)

0.02 (0%)

Current Ratio

8.54 (-31.66%)

12.5 (-15.67%)

14.83 (-47.70%)

28.35 (259.67%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,335,000 (-18.13%)

-$6,209,000 (4.36%)

-$6,492,000 (-32.41%)

-$4,903,000 (20.81%)

Enterprise Value (EV)

$111,640,222 (17.31%)

$95,170,270 (-35.56%)

$147,682,475 (27.70%)

$115,649,424 (168.04%)

Earnings Before Tax (EBT)

-$12,554,000 (-27.96%)

-$9,811,000 (27.83%)

-$13,595,000 (-4.95%)

-$12,954,000 (-29.30%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$12,517,000 (-28.18%)

-$9,765,000 (27.95%)

-$13,553,000 (-5.11%)

-$12,894,000 (-29.87%)

Invested Capital

$18,052,000 (-20.66%)

$22,754,000 (40.15%)

$16,236,000 (165.38%)

$6,118,000 (221.58%)

Working Capital

$18,862,000 (-19.14%)

$23,328,000 (-17.17%)

$28,163,000 (-18.92%)

$34,733,000 (324.61%)

Tangible Asset Value

$21,591,000 (-15.40%)

$25,522,000 (-16.08%)

$30,412,000 (-16.12%)

$36,257,000 (283.55%)

Market Capitalization

$112,628,222 (14.71%)

$98,181,270 (-42.82%)

$171,705,475 (20.19%)

$142,861,047 (191.52%)

Average Equity

$22,499,250 (-13.84%)

$26,114,750 (-17.67%)

$31,720,500 (3.06%)

$30,779,709 (337.97%)

Average Assets

$23,556,500 (-12.76%)

$27,001,250 (-17.56%)

$32,752,500 (3.63%)

$31,605,329 (309.08%)

Invested Capital Average

$20,668,000 (0.09%)

$20,649,250 (163.52%)

$7,836,000 (24.01%)

$6,318,701 (195.81%)

Shares

32,179,492 (3.57%)

31,070,022 (1.33%)

30,661,692 (2.38%)

29,949,905 (25.90%)